AXSOME THERAPEUTICS INC
AXSM · NASDAQ
Updated at 2026-10-14 12:34:30
- Today's High
- $166.55
- Today’s Low
- $155.68
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $169.50
- Previous Close
- $166.00
- Volume
- 663K
- Market Cap
- $8.69B
- P/E Ratio
- --
- EPS
- $-3.75
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- ONE WORLD TRADE CENTER, NEW YORK, NY, UNITED STATES, 10007
- Country
- US
- Listing Date
- 2015-11-19
- Fiscal Year End
- December
- Shares Outstanding
- 51.46M
- CIK
- 0001579428
- Website
- www.axsome.com
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$218.37M
2026-03-31
$191.2M
2025-12-31
$195.99M
2025-09-30
$170.99M
Operating Expenses
2026-06-30
$254.45M
2026-03-31
$239.83M
2025-12-31
$213.1M
2025-09-30
$205.18M
Net Income
2026-06-30
-$51.31M
2026-03-31
-$64.54M
2025-12-31
-$28.55M
2025-09-30
-$47.22M
Net Profit Margin
2026-06-30
-23.49%
2026-03-31
-33.75%
2025-12-31
-14.57%
2025-09-30
-27.62%
Earnings Per Share
2026-06-30
$-0.99
2026-03-31
$-1.26
2025-12-31
$-0.56
2025-09-30
$-0.94
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$46.75M
2026-03-31
-$60.99M
2025-12-31
-$24.68M
2025-09-30
-$43.69M
Effective Tax Rate
2026-06-30
-0.25%
2026-03-31
--
2025-12-31
-1.52%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $218.37M | $191.2M | $195.99M | $170.99M |
| Operating Expenses | $254.45M | $239.83M | $213.1M | $205.18M |
| Net Income | -$51.31M | -$64.54M | -$28.55M | -$47.22M |
| Net Profit Margin | -23.49% | -33.75% | -14.57% | -27.62% |
| Earnings Per Share | $-0.99 | $-1.26 | $-0.56 | $-0.94 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$46.75M | -$60.99M | -$24.68M | -$43.69M |
| Effective Tax Rate | -0.25% | -- | -1.52% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.